Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0002 (-50.00%)
Nov 18, 2025, 4:00 PM EST
Acura Pharmaceuticals Revenue
In the year 2021, Acura Pharmaceuticals had annual revenue of $1.56M, down -56.22%. Acura Pharmaceuticals had revenue of $36.00K in the quarter ending December 31, 2021, a decrease of -94.99%.
Revenue
1.56M
Revenue Growth
-56.22%
P/S Ratio
0.01
Revenue / Employee
173.67K
Employees
9
Market Cap
13.30K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 1.56M | -2.01M | -56.22% |
| Dec 31, 2020 | 3.57M | 913.00K | 34.36% |
| Dec 31, 2019 | 2.66M | 2.25M | 548.05% |
| Dec 31, 2018 | 410.00K | -2.56M | -86.18% |
| Dec 31, 2017 | 2.97M | -1.50M | -33.56% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| China New Energy Group Co. | 12.51M |
| Nuo Therapeutics | 2.61M |
Acura Pharmaceuticals News
- 4 years ago - Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03 - GlobeNewsWire
- 4 years ago - Acura Pharmaceuticals Provides Development Update on LTX-03 - GlobeNewsWire
- 4 years ago - Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results - GlobeNewsWire
- 4 years ago - Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results - GlobeNewsWire